Medical Condition News

RSS

Smart technology helps improve outcomes for patients with head and neck cancer

A federally funded, randomized clinical trial of 357 people receiving radiation for head and neck cancer, using mobile and sensor technology to remotely monitor patient symptoms, resulted in less severe symptoms related to both the cancer and its treatment (both general and cancer-related).

17 May 2018

New treatment regimen boosts survival for young adults and children with T-cell malignancies

In a federally funded, randomized phase III clinical trial performed by the Children's Oncology Group (COG), 90% of children and young adults with T-cell acute lymphoblastic leukemia (T-ALL) or T-cell lymphoblastic lymphoma (T-LL) were alive four years after starting treatment regimens on this trial, and 84% were cancer free.

17 May 2018

Brain abnormality linked to general risk for mental illness

A new study by researchers at Duke University reports an abnormality in visual regions of the brain that is associated with a person's general risk for mental illness.

17 May 2018

Pancreatic cancer patients with BRCA1 or BRCA2 mutations fare better on platinum-based chemotherapy

A small study of adults with the most common form of pancreatic cancer adds to evidence that patients with BRCA1 or BRCA2 gene mutations long linked to a high risk of breast cancer have poorer overall survival rates than those without the mutations.

17 May 2018

Rocket Pharma partners with Stanford University to advance FA and PKD gene therapy research

Rocket Pharmaceuticals, Inc., a leading U.S.-based multi-platform gene therapy company, and the Stanford University School of Medicine today announced a strategic collaboration to support the advancement of Fanconi Anemia and Pyruvate Kinase Deficiency gene therapy research.

17 May 2018

Scientists discover how unusually long strands of RNA help colon cancer cells avoid death

Researchers from Case Western Reserve University School of Medicine have discovered how unusually long strands of RNA help colon cancer cells avoid death, allowing unregulated growth.

17 May 2018

Senior diabetic patients can save significant cost if negotiated rebates are shared at pharmacy counter

Sharing a portion of negotiated rebates at the pharmacy counter could save seniors in Medicare with diabetes more than $350 annually, according to a new analysis from IHS Markit.

17 May 2018

Alexo Therapeutics marks next significant milestone by initiating ALX148 combination cohorts

Alexo Therapeutics, a clinical-stage immuno-oncology company developing therapies to block the CD47 checkpoint mechanism, today announced it has initiated ALX148 combination dosing with targeted antibody therapies in its Phase 1 clinical program in patients with advanced solid tumors and lymphoma.

17 May 2018

Cognitive decline in dementia is not reduced by high-intensity exercise

Results of a new study indicate that exercise does not delay the progression of cognitive impairment in older people with dementia.

17 May 2018

Researchers transplant retinal sheets derived from human embryonic stem cells in retinal degeneration mouse models

Researchers affiliated with the Kawasaki INnovation Gateway at SKYFRONT have developed new mouse models of retinal degeneration that enable transplantation of retinal sheets derived from human embryonic stem cells.

17 May 2018

International study finds viable treatment option for people with mild asthma

A large international study led by a Hamilton researcher has found a patient-centric treatment that works for people with mild asthma.

17 May 2018

Scientists disrupt two enzymes to shrink cancer cells

Before cell division, the long strings of the cell's DNA are wrapped tightly into the structures we know as chromosomes. This protects the cell's genetic material from physical and chemical damage.

17 May 2018

New study reveals the extent of brain damage due to elevated homocysteine

The amino acid homocysteine occurs naturally in the human body, generated as a byproduct of methionine metabolism.

17 May 2018

New mode of proton therapy for lung cancer developed by Beaumont shows promising results

"Beaumont researchers have invented a new mode of proton therapy for lung cancer," said Peyman Kabolizadeh, M.D., Ph.D., clinical director, Beaumont Proton Therapy Center in Royal Oak.

17 May 2018

Study aims to determine benefit of combining hyaluronic acid treatment with exercise for arthritis patients

A new study at Hospital for Special Surgery aims to determine if a hyaluronic acid treatment combined with an exercise program helps patients with knee arthritis more than exercise alone.

17 May 2018

Researcher develops small molecules that inhibit derailment of gene expression in cancer

Not everyone person who has a "cancer gene" will inevitably develop this disease in their lifetime. Thanks to a new area of research called epigenetics, we now know that many genes are only read under certain circumstances.

17 May 2018

New AI software accurately identifies commonest cause of stroke and dementia

Machine learning has detected one of the commonest causes of dementia and stroke, in the most widely used form of brain scan, more accurately than current methods.

17 May 2018

New insights regarding challenges in rare disease diagnosis, drug approval, and patient access

Value in Health, the official journal of ISPOR, announced today the publication of a series of articles offering important insight regarding the challenges in rare disease diagnosis, drug approval, and patient access.

17 May 2018

Bacterial signals are crucial to development of pre-leukemic myeloproliferation, study shows

A new study by researchers from the University of Chicago Medicine shows that bacterial signals are crucial to the development of a precursor condition to leukemia, which can be induced by disrupting the intestinal barrier or by introducing a bacterial infection.

17 May 2018

Mayo discovery could enable development of personalized ovarian, brain cancer treatments

Mayo Clinic researchers have discovered that a molecular communication pathway – thought to be defective in cancer – is a key player in determining the effectiveness of measles virus oncolytic cancer treatment in ovarian and aggressive brain cancers.

17 May 2018

Medical Condition News

Smart technology helps improve outcomes for patients with head and neck cancer

New treatment regimen boosts survival for young adults and children with T-cell malignancies

Brain abnormality linked to general risk for mental illness

Pancreatic cancer patients with BRCA1 or BRCA2 mutations fare better on platinum-based chemotherapy

Rocket Pharma partners with Stanford University to advance FA and PKD gene therapy research

Scientists discover how unusually long strands of RNA help colon cancer cells avoid death

Senior diabetic patients can save significant cost if negotiated rebates are shared at pharmacy counter

Alexo Therapeutics marks next significant milestone by initiating ALX148 combination cohorts

Cognitive decline in dementia is not reduced by high-intensity exercise

Researchers transplant retinal sheets derived from human embryonic stem cells in retinal degeneration mouse models

International study finds viable treatment option for people with mild asthma

Scientists disrupt two enzymes to shrink cancer cells

New study reveals the extent of brain damage due to elevated homocysteine

New mode of proton therapy for lung cancer developed by Beaumont shows promising results

Study aims to determine benefit of combining hyaluronic acid treatment with exercise for arthritis patients

Researcher develops small molecules that inhibit derailment of gene expression in cancer

New AI software accurately identifies commonest cause of stroke and dementia

New insights regarding challenges in rare disease diagnosis, drug approval, and patient access

Bacterial signals are crucial to development of pre-leukemic myeloproliferation, study shows

Mayo discovery could enable development of personalized ovarian, brain cancer treatments

Advancing Menopause Care: Non-Hormonal Treatments for Vasomotor Symptoms

Building quality into drug development for safer, faster medicines

How Pulp Fixin Is Turning Paper into High-Performance Sustainable Labware

Latest News